Заказ 30689 (200 грн.)

II. Questions on strategy

4. In what life-cycle stage was Crioestaminal in 2010? 

5. The company’s management assigns you to rethink the financing sources of growth. How does Riverside fit into this, and why?

6. What is the investment story here and where do you see risks?

7. What type of complementary (add-on) investments would you consider?

8. What exit strategies exist? What are the advantages and disadvantages of these?